SENSE Body Coil 1.5T with identification; used in the ACS NT, Intera 1.5T and Achieva 1.5T MR system
Published March 9, 2016 · Recall initiated: July 6, 2015
Summary
FDA records medical device Class II recall Z-1024-2016, published March 9, 2016 and initiated July 6, 2015. Recalling firm: Philips Electronics North America Corporation; Status: Terminated; Reported quantity: 5672; Lot: 4522 131 5575x 4522 132 1985x 4522 132 7619x 4598 000 5187x 4598 000 5189x 4598 003 59051. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Wrong positioning of the coil cables can create unintended resonances via the patient or elevated coil cable temperature due to coupling to the QBC. The combined use of the Sense coil, high SAR level scanning and placement of the cables contrary to instructions for use can lead to patient burns.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Philips Electronics North America Corporation
- Distributor
- US: Nationwide OUS: Canada, Afghanistan Albania Algeria Andorra Argentina Australia Austria Azerbaijan Bahamas Bangladesh Belarus Belgium Bolivia Bosnia and Herzegovina Botswana Brazil Burkina Faso Chile China Colombia Columbia Congo, Democratic Costa Rica Croatia Cyprus Czech Republic Denmark Dominican Republic Ecuador Egypt Estonia Ethiopia Finland France Georgia Germany Ghana Greece Guadeloupe Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Japan Jersey Jordan Kazakhstan Kenya Korea, Republic of Kuwait Kyrgyzstan Latvia Lebanon Libya Lithuania Luxembourg Malaysia Malta Martinique Mauritius Mexico Monaco Mongolia Morocco Mozambique Nepal Netherlands New Caledonia New Zealand Norway Oman Pakistan Palestinian territory, occupied Panama Papua New Guinea Peru Philippines Poland Portugal Puerto Rico Romania Russian Federation Rwanda Saudi Arabia Serbia Singapore Slovakia Slovenia South Africa Spain Sri Lanka Sudan Sweden Switzerland Syrian Arab Republic Taiwan Tanzania Thailand Tunisia Turkey Uganda Ukraine United Arab Emirates United Kingdom Venezuela Viet Nam Yemen Zimbabwe
- Lot
- 4522 131 5575x 4522 132 1985x 4522 132 7619x 4598 000 5187x 4598 000 5189x 4598 003 59051
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAINTEGRIS CV, System Code 722030 Vascular, cardiovascular and neurovascular imaging applications, CardiacOctober 3, 2018
- FDAAllura Xper FD2O, System Code 722006 Vascular, cardiovascular and neurovascular imaging applications, CardiacOctober 3, 2018
- FDAAIIuraXperFDlO/10, System Code 722011 Vascular, cardiovascular and neurovascular imaging applications, CardiacOctober 3, 2018
- FDAAIIura Xper F010 DR Table, System Code 722022 Vascular, cardiovascular and neurovascular imaging applications,October 3, 2018
- FDAMedtronic Custom Perfusion Tubing Pack, Rx, Sterile EO. Terumo Cardiovascular Systems (Terumo CVS) hasMarch 9, 2016
- FDANeoCoil 3.0T GEM Flex Coil. The 3.0T GEM Flex coil system includes three sizes of coil arrays and oneMarch 9, 2016
Questions about this recall
Was SENSE Body Coil 1.5T with identification; used in the ACS NT, Intera 1.5T and Achieva 1.5T MR system recalled?
Yes. FDA published recall Z-1024-2016 on March 9, 2016. Reported hazard: Wrong positioning of the coil cables can create unintended resonances via the patient or elevated coil cable temperature due to coupling to the QBC. The combined use of the Sense coil, high SAR level scanning and placement of the cables contrary to instructions for use can lead to patient burns.
What should I do if I have this product?
Voluntary: Firm initiated · Letter